Research workbench
Cryo-EM structure of T275P katg from M. tuberculosis
Analyse Cryo-EM structure of T275P katg from M. tuberculosis in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 7A8Z
- Type
- protein
- Length
- 1,103 residues
- Chains
- 2
- Method
- electron microscopy
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Catalase-peroxidase
- EC
- 1.11.1.21
- UniProt
- A0A0D5ZBI4
- Pockets
- 20 · best druggability 0.74
Structure
electron microscopy · 2 distinct chains · 45% helix, 4% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Catalase-peroxidase (EC 1.11.1.21) | protein | 553 | 44% helix, 4% strand | A0A0D5ZBI4 |
| B | Catalase-peroxidase (EC 1.11.1.21) | protein | 550 | 46% helix, 4% strand | A0A0D5ZBI4 |
Pockets
20 pockets found on a 1 Å grid, 9 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 962 | 0.74 | 0.77 | 83 | empty |
| 2 | 99 | 0.72 | 0.94 | 24 | empty |
| 3 | 773 | 0.71 | 0.77 | 68 | empty |
| 4 | 73 | 0.61 | 0.90 | 18 | empty |
| 5 | 115 | 0.60 | 0.86 | 30 | empty |
Interfaces
1 interface between chains.
- A–B · 1706 Ų buried · 11 hydrogen bonds · protein-protein
Compared structures
- 7A8Z · Cryo-EM structure of T275P KatG from M. tuberculosis · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A0A0D5ZBI4
- Elsewhere: RCSB PDB 7A8Z · PDBe 7A8Z · UniProt A0A0D5ZBI4
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.